Nuvation Bio Inc’s recently made public that its CHIEF PEOPLE OFFICER Markel Stacy acquired Company’s shares for reported $17100.0 on Jun 18 ’25. In the deal valued at $1.71 per share,10,000 shares were bought. As a result of this transaction, Markel Stacy now holds 29,591 shares worth roughly $0.11 million.
Then, Sauvage Philippe bought 4,000 shares, generating $7,160 in total proceeds. Upon buying the shares at $1.79, the Chief Financial Officer now owns 9,902 shares.
Before that, Sauvage Philippe bought 3,300 shares. Nuvation Bio Inc shares valued at $6,056 were divested by the Chief Financial Officer at a price of $1.83 per share. As a result of the transaction, Sauvage Philippe now holds 5,902 shares, worth roughly $21719.36.
Jefferies initiated its Nuvation Bio Inc [NUVB] rating to a Buy in a research note published on September 30, 2025; the price target was $10. A number of analysts have revised their coverage, including Citizens JMP’s analysts, who began to cover the stock in late April with a ‘”a Mkt outperform”‘ rating. Jefferies also remained covering NUVB and has increased its forecast on March 27, 2024 with a “Buy” recommendation from previously “Hold” rating. BTIG Research revised its rating on March 26, 2024. It rated NUVB as “a Buy” which previously was an “a Neutral”.
Price Performance Review of NUVB
On Monday, Nuvation Bio Inc [NYSE:NUVB] saw its stock fall -1.60% to $3.68. Over the last five days, the stock has lost -2.39%. Nuvation Bio Inc shares have risen nearly 66.52% since the year began. Nevertheless, the stocks have risen 38.35% over the past one year.
How much short interest is there in Nuvation Bio Inc?
A steep rise in short interest was recorded in Nuvation Bio Inc stocks on 2025-09-30, growing by 3.84 million shares to a total of 71.97 million shares. Yahoo Finance data shows the prior-month short interest on 2025-08-29 was 68.13 million shares. There was a rise of 5.34%, which implies that there is a positive sentiment for the stock.
